Due to ACCME requirements, and the data protection of all presenters, all communications related to platform and/or ePoster presentations are kept strictly between the platform and/or ePoster presenter and the WORLDSymposium CME Programs team.

Any presentations submitted to WORLDSymposium for CME review are kept strictly confidential, and are not shared beyond the required CME review team. The presentations will not be available to WORLDSymposium attendees until the platform session is first presented, and then will be available “on-demand” on the virtual website until March 31, 2023, after which time the virtual platform will be shut down.

All submitted ePosters will be available starting on Wednesday, February 22, 2023, when the ePosters open, currently scheduled for 3:00 PM PST. ePosters will also available on the virtual platform until March 31, 2023.

Submitted abstracts will be available to all registered attendees starting on Tuesday, February 22, 2023. Submitted abstracts are available to the general public when Elsevier publishes the February issue of Molecular Genetics and Metabolism (MGM). WORLDSymposium staff have no control over the publication date, however, anyone may sign up with Elsevier for publication updates.

Presentations are not available to anyone other than the WORLDSymposium development team until the time the presentation is first presented live during the conference, and then the presentations are available “on-demand” to the registered attendees until March 31, 2023.

First authors are required to acknowledge that they are authorizing WORLDSymposium to provide their ePoster and/or presentation to the WORLDSymposium audience. If they choose not to authorize WORLDSymposium to provide their presentation, their presentation will be removed from the agenda and all databases.